CYTO
vs
S&P 500
CYTO
S&P 500
Over the past 12 months, CYTO has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +15% growth.
Stocks Performance
CYTO vs S&P 500
Performance Gap
CYTO vs S&P 500
Performance By Year
CYTO vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Altamira Therapeutics Ltd
Glance View
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders.